UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Coût par patient répondeur associé au traitement du purpura thrombopénique immunologique primaire par romiplostim et rituximab chez l’adulte en France

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2014-05, Vol.21 (2), p.85-93

2014

Volltextzugriff (PDF)

Clinical characteristics and prevalence of cardiovascular disease risk factors in subjects screened for familial hypercholesterolemia – A cross sectional study in The Netherlands

Atherosclerosis, 2016-09, Vol.252, p.e203-e203

2016

Volltextzugriff (PDF)

Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden

Acta haematologica, 2021, Vol.144 (5), p.519-527

2021

Volltextzugriff (PDF)

Clinical characteristics and LDL-cholesterol management in patients with cardiovascular event and/or diabetes in the Netherlands

Atherosclerosis, 2016-09, Vol.252, p.e12-e12

2016

Volltextzugriff (PDF)

Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy: A Systematic Review

Value in health, 2017-10, Vol.20 (9), p.A620-A621

2017

Volltextzugriff (PDF)

Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic

Value in health, 2014-11, Vol.17 (7), p.A533-A533

2014

Volltextzugriff (PDF)

Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2014-05, Vol.21 (2), p.85

2014

Volltextzugriff (PDF)

PCR212 A Novel Approach to Capturing Real-World Reasons Behind Use and Satisfaction of NVX-CoV2373 Booster Use Among German Adults: Direct-to-Patient Enrollment

Value in health, 2023-12, Vol.26 (12), p.S490

2023

Volltextzugriff (PDF)

RWD103 NVX-CoV2373 Patient Characteristics in Germany: Real-World Retrospective Database Study Shows Most Vaccine Recipients Were Among the High Risk Category

Value in health, 2023-12, Vol.26 (12), p.S524

2023

Volltextzugriff (PDF)

EE593 Cost-Effectiveness Model of COVID-19 Vaccination: The United Kingdom Perspective

Value in health, 2023-12, Vol.26 (12), p.S167

2023

Volltextzugriff (PDF)

The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

Value in health, 2017-10, Vol.20 (9), p.A605

2017

Volltextzugriff (PDF)

PCV30 - The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

Value in health, 2017-10, Vol.20 (9), p.A605-A605

2017

Volltextzugriff (PDF)

Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain

Clinical therapeutics, 2017-04, Vol.39 (4), p.771-786.e3

2017

Volltextzugriff (PDF)

Real-World Characteristics And Risk Of Cardiovascular Events In High Cardiovascular Risk Patients In France

Atherosclerosis, 2019-08, Vol.287, p.e180-e180

2019

Volltextzugriff (PDF)

PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH

Value in health, 2011, Vol.14 (3), p.A60-A60

2011

Volltextzugriff (PDF)

PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in health, 2011, Vol.14 (7), p.A439-A440

2011

Volltextzugriff (PDF)

P2561Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

TP1 TREATMENT PATTERNS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN GERMANY

Value in health, 2019-11, Vol.22, p.S923-S923

2019

Volltextzugriff (PDF)

Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000

Journal of clinical oncology, 2004-09, Vol.22 (17), p.3524-3530

2004

Volltextzugriff (PDF)

Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

Value in health, 2016-11, Vol.19 (7), p.A396-A397

2016

Volltextzugriff (PDF)

PRM216 - Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

Value in health, 2016-11, Vol.19 (7), p.A396-A397

2016

Volltextzugriff (PDF)

CV4 - PATIENT AND CAREGIVER INDIRECT COSTS AFTER ACUTE CARDIOVASCULAR EVENTS IN EUROPE

Value in health, 2018-10, Vol.21, p.S6-S6

2018

Volltextzugriff (PDF)

For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

Value in health, 2016-11, Vol.19 (7), p.A645-A646

2016

Volltextzugriff (PDF)

PCV54 - For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

Value in health, 2016-11, Vol.19 (7), p.A645-A646

2016

Volltextzugriff (PDF)

AD1 - ASSOCIATION OF ADHERENCE AND TREATMENT INTENSITY WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATHEROSCLEROSIS OR OTHER CARDIOVASCULAR RISK FACTORS TREATED WITH STATINS AND/OR EZETIMIBE

Value in health, 2018-10, Vol.21, p.S2-S2

2018

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(105)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Coût par patient répondeur associé au traitement du purpura thrombopénique immunologique primaire par romiplostim et rituximab chez l’adulte en France

Clinical characteristics and prevalence of cardiovascular disease risk factors in subjects screened for familial hypercholesterolemia – A cross sectional study in The Netherlands

Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden

Clinical characteristics and LDL-cholesterol management in patients with cardiovascular event and/or diabetes in the Netherlands

Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy: A Systematic Review

Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic

Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France

PCR212 A Novel Approach to Capturing Real-World Reasons Behind Use and Satisfaction of NVX-CoV2373 Booster Use Among German Adults: Direct-to-Patient Enrollment

RWD103 NVX-CoV2373 Patient Characteristics in Germany: Real-World Retrospective Database Study Shows Most Vaccine Recipients Were Among the High Risk Category

EE593 Cost-Effectiveness Model of COVID-19 Vaccination: The United Kingdom Perspective

The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

PCV30 - The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain

Real-World Characteristics And Risk Of Cardiovascular Events In High Cardiovascular Risk Patients In France

PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH

PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

P2561Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe

TP1 TREATMENT PATTERNS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN GERMANY

Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000

Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

PRM216 - Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

CV4 - PATIENT AND CAREGIVER INDIRECT COSTS AFTER ACUTE CARDIOVASCULAR EVENTS IN EUROPE

For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

PCV54 - For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

AD1 - ASSOCIATION OF ADHERENCE AND TREATMENT INTENSITY WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATHEROSCLEROSIS OR OTHER CARDIOVASCULAR RISK FACTORS TREATED WITH STATINS AND/OR EZETIMIBE

Suchergebnisse filtern